T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.


CD95(APO-1 / Fas) ligand (CD95L) gene expression is critically involved in activation-induced T cell apoptosis. We and other have previously shown that HIV-1 Tat which is essential for efficient HIV gene expression sensitizes CD95-mediated apoptosis and up-regulates CD95L expression in T cells. In the present study we have investigated the regulatory mechanism for CD95L expression. Two NF-kappaB binding sites are localized at - 537 to - 521 and - 57 to - 47 (relative to the transcription start site) of the human CD95L promoter. We show that both elements bind to NF-kappaB and SP-1 transcription factors and NF-kappaB is involved in transactivation of the CD95L promoter upon T cell activation. Mutations at each NF-kappaB site by two base pair substitutions resulted in 30 - 70 % reduction of the promoter activity. The effect of Tat on the human CD95L promoter activity was mapped to the same sites. Mutation of each NF-kappaB site also impaired the effect of Tat on CD95L promotor activity. We also show that ectopic expression of Tat protein in Jurkat T cells greatly increases NF-kappaB binding to its target DNA. Our studies provide evidence that Tat-enhanced CD95L expression is regulated at least in part by the NF-kappaB sites of the promoter.


Citations per Year

505 Citations

Semantic Scholar estimates that this publication has 505 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{LiWeber2000TCA, title={T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.}, author={Min Li-Weber and Oskar Laur and Katy Dern and PH Krammer}, journal={European journal of immunology}, year={2000}, volume={30 2}, pages={661-70} }